Show simple item record

dc.contributor.authorCardona-Ospina, J.A.
dc.contributor.authorTrujillo, A.M.
dc.contributor.authorJiménez-Posada, E.V.
dc.contributor.authorSepúlveda-Arias, J.C.
dc.contributor.authorTabares-Villa, F.A.
dc.contributor.authorAltieri-Rivera, J.S.
dc.contributor.authorMonsalve, A.
dc.contributor.authorRestrepo-Chica, J.
dc.contributor.authorOsorio, D.
dc.contributor.authorEspinoza, D.
dc.contributor.authorZhu, Y.
dc.contributor.authorCastrillón-Spitia, J.D.
dc.contributor.authorHenao-SanMartin, V.
dc.contributor.authorMurillo-Garcia, D.R.
dc.contributor.authorMillán, N.
dc.contributor.authorOlaya, S.X.
dc.contributor.authorValencia-Montoya, A.M.
dc.contributor.authorBedoya-Arias, H.A.
dc.contributor.authorVillamizar-Peña, R.
dc.contributor.authorGutierrez-Ocampo, E.
dc.contributor.authorHolguin-Rivera, Y.
dc.contributor.authorCortés-Bonilla, I.
dc.contributor.authorCardona-Trujillo, M.C.
dc.contributor.authorGarcía-Barco, A.
dc.contributor.authorBonilla-Aldana, D.K.
dc.contributor.authorLagos-Grisales, G.J.
dc.contributor.authorRodríguez-Morales, A.J.
dc.contributor.authorCollins, M.H.
dc.date.accessioned2025-10-31T18:35:09Z
dc.date.available2025-10-31T18:35:09Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5244
dc.description.abstractObjectives: Aedes-borne viruses (ABV) affect humans on every inhabited continent and frequently cause epidemics. Recent epidemics of chikungunya and Zika viruses (ZIKV) highlight that preparedness for future epidemics requires assessment of susceptibility, particularly among high-risk groups. We sought to determine immunity against the three major circulating ABV among pregnant women in an ABV-endemic area of Colombia. Methods: A cross-sectional seroprevalence study was performed, enrolling women presenting to Labor and Delivery. Cord blood and maternal peripheral blood samples were obtained. IgG seroprevalence to flaviviruses and chikungunya was determined by ELISA. An abbreviated neutralization test was used to estimate the frequency and magnitude of immunity to Zika and four dengue serotypes. Cluster analyses explored epidemiologic factors associated with seroprevalence. Results: Most women exhibited high levels of neutralizing antibodies to one or more ABV; however, nearly 20% were seronegative for flaviviruses. Our research took place after the epidemic peak of the ZIKV outbreak in Colombia in 2016. However, only 20% of pregnant women had high levels of Zika-neutralizing antibodies consistent with likely protective immunity to ZIKV. Conclusion: Hence, a high proportion of pregnant women in Risaralda remain susceptible to one or more ABV including the teratogenic ZIKV, indicating a risk for future epidemics in this region.en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofurn:issn:1878-3511
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectDengue and Zika Virus Dynamics in Public Healthen_US
dc.subjectZika Virus Impact on Congenital Health Outcomesen_US
dc.titleSusceptibility to endemic Aedes-borne viruses among pregnant women in Risaralda, Colombiaen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1016/j.ijid.2022.07.017
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.08
dc.type.otherResearch article
dc.identifier.journalInternational Journal of Infectious Diseases
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2